Shirin Emtenani
6PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 28, 2026
Complement Activation May Drive the Pathogenicity of Anti-α6 and Anti-β4 Integrin Antibodies In Vivo.Gefei Du, Shirin Emtenani, Dennis Niese
|Feb 27, 2026
Selective Complement Inhibition in Anti-p200 Pemphigoid: Immune Infiltrate Profiles and Therapeutic Implications Compared to Bullous Pemphigoid.Shirin Emtenani, Tina Rastegar Lari, Charlotte Kiehne
|Nov 27, 2025
Bullous Pemphigoid Develops Independently of DAP12.Manuela Pigors, Sabrina Patzelt, Maëlys Brudey
|Feb 26, 2025
Localization of Lesions in Autoimmune Blistering Diseases Is Independent of Site-Specific Target Antigen Expression.Tina Rastegar Lari, Louis Macias, Lara Robrahn
|Sep 02, 2024
Granzyme B inhibition reduces autoantibody-induced dermal-epidermal separation in an ex vivo model of epidermolysis bullosa acquisita.Shirin Emtenani, Hélène Lebhar, Christopher P Marquis
|Nov 06, 2023
Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade.Manuela Pigors, Sabrina Patzelt, Niklas Reichhelm
Pageof 1
Frequent Collaborators
3 joint publications
Sabrina Patzelt
3 joint publications
Katja Bieber
2 joint publications
Manuela Pigors
2 joint publications
Stephanie Goletz
2 joint publications
Ralf J Ludwig
1 joint publications
Stanislav Khil'chenko
1 joint publications
Mayumi Kamaguchi
1 joint publications
Gabriele Köhl
1 joint publications
Jörg Köhl
1 joint publications
Lars Komorowski
